Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Pharmacological Research
|
August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Paola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
Journal of Neurology
|
July 12, 2023
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint
Panayiota Petrou, Anat Achiron, Esther Ganelin Cohen, et al.
JAMA Neurology
|
January 12, 2016
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials
Panayiota Petrou, Yael Gothelf, Zohar Argov, et al.
Frontiers in Immunology
|
October 15, 2024
Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands
Ayal Rozenberg, Shahar Shelly, Adi Vaknin-Dembinsky, et al.
Brain and Behavior
|
June 28, 2024
The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
Esther Ganelin-Cohen, Chen Buxbaum, Noam Bosak, et al.
Archives of Neurology
|
October 13, 2010
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis
Dimitrios Karussis, Clementine Karageorgiou, Adi Vaknin-Dembinsky, et al.
International Immunopharmacology
|
March 18, 2020
RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation
Yael Ben-David, Sara Kagan, Hagit Cohen Ben-Ami, et al.
Journal of the Neurological Sciences
|
December 7, 2021
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage
Shay Menascu, Aviva Fattal-Valevski, Adi Vaknin-Dembinsky, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 25, 2026
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies
Lior Fuchs, Ifat Vigiser, Hadar Kolb, et al.
Plos One
|
December 29, 2012
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial
Dimitrios Karussis, Hagai Shor, Julia Yachnin, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Pharmacological Research
|
August 12, 2019
MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine
Paola Cavalcante, Tehila Mizrachi, Claudia Barzago, et al.
Journal of Neurology
|
July 12, 2023
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint
Panayiota Petrou, Anat Achiron, Esther Ganelin Cohen, et al.
JAMA Neurology
|
January 12, 2016
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials
Panayiota Petrou, Yael Gothelf, Zohar Argov, et al.
Frontiers in Immunology
|
October 15, 2024
Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands
Ayal Rozenberg, Shahar Shelly, Adi Vaknin-Dembinsky, et al.
Brain and Behavior
|
June 28, 2024
The effect of COVID-19 vaccination on multiple sclerosis activity as reflected by MRI
Esther Ganelin-Cohen, Chen Buxbaum, Noam Bosak, et al.
Archives of Neurology
|
October 13, 2010
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis
Dimitrios Karussis, Clementine Karageorgiou, Adi Vaknin-Dembinsky, et al.
International Immunopharmacology
|
March 18, 2020
RIC3, the cholinergic anti-inflammatory pathway, and neuroinflammation
Yael Ben-David, Sara Kagan, Hagit Cohen Ben-Ami, et al.
Journal of the Neurological Sciences
|
December 7, 2021
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage
Shay Menascu, Aviva Fattal-Valevski, Adi Vaknin-Dembinsky, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 25, 2026
Heterogeneous response to efgartigimod in real-world experience with myasthenia gravis: Predictors and treatment strategies
Lior Fuchs, Ifat Vigiser, Hadar Kolb, et al.
Plos One
|
December 29, 2012
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial
Dimitrios Karussis, Hagai Shor, Julia Yachnin, et al.
Page
of 9